Cargando…
The evolution of lung cancer and impact of subclonal selection in TRACERx
Lung cancer is the leading cause of cancer-associated mortality worldwide(1). Here we analysed 1,644 tumour regions sampled at surgery or during follow-up from the first 421 patients with non-small cell lung cancer prospectively enrolled into the TRACERx study. This project aims to decipher lung can...
Ejemplares similares
-
Evolutionary characterisation of lung adenocarcinoma morphology in TRACERx
por: Karasaki, Takahiro, et al.
Publicado: (2023) -
The evolution of non-small cell lung cancer metastases in TRACERx
por: Al Bakir, Maise, et al.
Publicado: (2023) -
Body composition and lung cancer-associated cachexia in TRACERx
por: Al-Sawaf, Othman, et al.
Publicado: (2023) -
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA
por: Abbosh, Christopher, et al.
Publicado: (2023) -
Genomic–transcriptomic evolution in lung cancer and metastasis
por: Martínez-Ruiz, Carlos, et al.
Publicado: (2023)